
    
      Evaluation of Device Features and Diagnostics

        -  Programmed parameters: Advanced pacemaker features (Autocapture, Auto sensitivity
           control (ASC), Ventricular Intrinsic Preference (VIPÂ®), Patient Notifier, RF telemetry,
           and newer advanced features)

        -  Device and lead measurements

        -  Number of AT/AF, VT/VF, PMT and AMS episodes

      Evaluation of Clinical Parameters

        -  Indication for device implantation

        -  Cardiac and arrhythmia history

        -  Cardiac drug utilization

        -  Cardiac events: incidence and onset of symptomatic atrial fibrillation (AF), onset of
           heart failure (HF), incidence and onset of angina, occurrence of myocardial infarction
           (MI), occurrence of transient ischemic attack (TIA)/ischemic stroke, and occurrence of
           hemorrhagic stroke

        -  Modified Specific Activity Scale (SAS)

        -  Intrinsic QRS duration

        -  Left ventricular ejection fraction (LVEF)

        -  Adverse events

        -  All-cause, cardiovascular and heart failure hospitalizations

        -  All-cause, cardiovascular and heart failure mortality
    
  